Feasibility of a Developmentally-tailored Mobile App for Tracking Mood and Pain in Children With Migraine
WithdrawnNot applicableNCT05337930
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to inform the continued development of a mobile app intended to support the treatment of CYP with migraine. After extensive public and patient involvement, Happyr Health has developed a mobile app that allows children and young people to track headache attacks and emotional wellbeing and to access coping techniques. With the use of gamification and storytelling elements, the app aims to engage children to be an active part in tracking and coping with their headaches. The outcomes of this study will inform future adaptations and development cycles of the Happyr Health app. 15 participants aged 10-16 will access the Happyr app for 8 weeks (= intervention). Primary outcomes of acceptability and implementation will be measured via surveys following the 8-week intervention in the app.
Study details
- Official title
- 'Happyr Tracking': Feasibility of a Developmentally-tailored Mobile App for Tracking Mood and Pain in Children With Migraine
- Conditions
- Primary Headache Disorder
- Interventions
- Device: Happyr App
- Sponsor
- Happyr Ltd
- Collaborators
- The Leeds Teaching Hospitals NHS Trust
- Start date
- 2022-08-04
- Primary completion
- 2023-02
- Sex
- All
- Age range
- from 10 Years to 16 Years
- Results posted
- No results posted in this snapshot
- Countries
- United Kingdom
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * With recurrent headaches (at least 3x per month) * Access to a device (Android or iOS smartphone) * Access to internet connection * English-speaking Exclusion Criteria: * Secondary headaches * Continuous headache * Severe cognitive impairments * Major comorbid medical or psychiatric illnesses (e.g. severe anxiety disorder)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05337930